Breaking News, Collaborations & Alliances

X-Chem, Janssen in Inflammatory Disease R&D Alliance

X-Chem will apply its discovery engine to identify novel compounds

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

X-Chem, Inc. has entered a multi-target collaboration with Janssen Biotech, Inc. (Janssen) focused on the discovery and development of candidates for the treatment of inflammatory diseases. The collaboration is being facilitated by Johnson & Johnson Innovation in Boston. X-Chem will apply its discovery engine, powered by a high diversity DNA-encoded small molecule library, to identify novel compounds targeting proteins involved in the inflammatory response. Janssen has an exclusive option ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters